Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVI-014 vs Filgrastim in Breast Cancer Patients at Risk of Neutropenia
NCT00497809Phase 2Completed
- Sponsor
- AviGenics
- Start
- Aug 2007
- Primary completion
- Jul 2008
- Modality
- Cytokines & Interferons
- Countries
- 2
01
Overview
A Phase 2 trial of filgrastim in neutropenia, sponsored by AviGenics. Started Aug 2007; status: completed.
02
Drugs
filgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT00497809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00497809.